A Combination Therapy of Nicotinamide and Progesterone Improves Functional Recovery following Traumatic Brain Injury

Journal of Neurotrauma

Volumn 32, Issue 11, 2015, Pages 765-779

  Peterson, Todd C ^a   Hoane, Michael R ^a   Mcconomy, Keith S ^a   Farin, Fred M ^b   Bammler, Theo K ^b   MacDonald, James W ^b   Kantor, Eric D ^b   Anderson, Gail D ^b  

^a SOUTHERN ILLINOIS UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Controlled cortical impact; Nicotinamide; Polytherapy; Progesterone; Recovery of function; Traumatic brain injury

Indexed keywords

NICOTINAMIDE; PROGESTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CONTUSION; CONTINUOUS INFUSION; CONTROLLED STUDY; CONVALESCENCE; CRANIOTOMY; DRUG EFFICACY; GENE EXPRESSION; HISTOPATHOLOGY; LOADING DRUG DOSE; MALE; MICROARRAY ANALYSIS; MONOTHERAPY; MOTOR PERFORMANCE; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; RAT; SENSORIMOTOR CORTEX; TASK PERFORMANCE; TRAUMATIC BRAIN INJURY; TREATMENT DURATION; ANIMAL; BRAIN INJURIES; COMBINATION DRUG THERAPY; DRUG EFFECTS; GENETICS; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN INJURIES; DRUG THERAPY, COMBINATION; MALE; NIACINAMIDE; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION;

EID: 84930317060     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2014.3530     Document Type: Article

References (70)

1. Schouten, J.W. (2007). Neuroprotection in traumatic brain injury: a complex struggle against the biology of nature. Curr. Opin. Crit. Care 13, 134-142.
2. Faden, A. and Stoica, B. (2007). Neuroprotection: Challenges and opportunities. Arch. Neurology 64, 794-800.
3. Hoane, M.R., Akstulewicz, S.L., and Toppen, J. (2003). Treatment with vitamin B3 improves functional recovery and reduces GFAP expression following traumatic brain injury in rats. J. Neurotrauma 20, 1189-1199.
4. Hoane, M.R., Gilbert, D.R., Holland, M.A., and Pierce, J.L. (2006). Nicotinamide reduces acute cortical neuronal death and edema in the traumatically injured brain. Neurosci. Lett. 408, 35-39.
5. Hoane, M.R., Kaplan, S.A., and Ellis, A.L. (2006). The effects of nicotinamide on apoptosis and blood-brain barrier breakdown following traumatic brain injury. Brain Res. 1125, 185-193.
6. Hoane, M.R., Tan, A.A., Pierce, J.L., Anderson, G.D., and Smith, D.C. (2006). Nicotinamide treatment reduces behavioral impairments and provides cortical protection after fluid percussion injury in the rat. J. Neurotrauma 23, 1535-1548.
7. Holland, M.A., Tan, A.A., Smith, D.C., and Hoane, M.R. (2008). Nicotinamide treatment provides acute neuroprotection and GFAP regulation following fluid percussion injury. J. Neurotrauma 25, 140-152.
8. Quigley, A., Tan, A.A., and Hoane, M.R. (2009). The effects of hypertonic saline and nicotinamide on sensorimotor and cognitive function following cortical contusion injury in the rat. Brain Res. 1304, 138-148.
9. Peterson, T.C., Anderson, G.D., Kantor, E.D., and Hoane, M.R. (2012). A comparison of the effects of nicotinamide and progesterone on functional recovery of cognitive behavior following cortical contusion injury in the rat. J. Neurotrauma 29, 2823-2830.
10. Swan, A.A., Chandrashekar, R., Beare, J., and Hoane, M.R. (2011). Preclinical efficacy testing in middle-aged rats: nicotinamide, a novel neuroprotectant, demonstrates diminished preclinical efficacy after controlled cortical impact. J. Neurotrauma 28, 431-440.
11. Vonder Haar, C., Anderson, G.D., and Hoane, M.R. (2011). Continuous nicotinamide administration improves behavioral recovery and reduces lesion size following bilateral frontal controlled cortical impact injury. Behav. Brain Res. 224, 311-317.
12. Goffus, A.M., Anderson, G.D., and Hoane, M. (2010). Sustained delivery of nicotinamide limits cortical injury and improves functional recovery following traumatic brain injury. Oxid. Med. Cell. Longev. 3, 145-152.
13. Hoane, M.R., Pierce, J.L., Kauffman, N.A., and Beare, J. (2008). Variation in chronic nicotinamide treatment after traumatic brain injury can alter components of functional recovery independent of histological damage. Oxid Med Cell Longev 1, 46-53.
14. Maiese, K. and Chong, Z.Z. (2003). Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain. Trends Pharmacol. Sci. 24, 228-232.
15. Ying, W. (2008). NAD+ /NADH and NADP+ /NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid. Redox Signal. 10, 179-206.
16. Choi, D.W. (1992). Excitotoxic cell death. J. Neurobiol. 23, 1261-1276.
17. Raghupathi, R. (2004). Cell death mechanisms following traumatic brain injury. Brain Pathol. 14, 215-222.
18. Kolthur-Seetharam, U., Dantzer, F., McBurney, M.W., de Murcia, G., and Sassone-Corsi, P. (2006). Control of AIF-mediated cell death by the functional interplay of SIRT1 and PARP-1 in response to DNA damage. Cell Cycle 5, 873-877.
19. Clark, R.S., Vagni, V.A., Nathaniel, P.D., Jenkins, L.W., Dixon, C.E., and Szabo, C. (2007). Local administration of the poly(ADP-ribose) polymerase inhibitor INO-1001 prevents NAD+ depletion and improves water maze performance after traumatic brain injury in mice. J. Neurotrauma 24, 1399-1405.
20. LaPlaca, M.C., Zhang, J., Raghupathi, R., Li, J.H., Smith, F., Bareyre, F.M., Snyder, S.H., Graham, D.I., and McIntosh, T.K. (2001). Pharmacologic inhibition of poly(ADP-ribose) polymerase is neuroprotective following traumatic brain injury in rats. J. Neurotrauma 18, 369-376.
21. Besson, V.C., Croci, N., Boulu, R.G., Plotkine, M., and Marchand-Verrecchia, C. (2003). Deleterious poly(ADP-ribose)polymerase-1 pathway activation in traumatic brain injury in rat. Brain Res. 989, 58-66.
22. Endres, M., Wang, Z.Q., Namura, S., Waeber, C., and Moskowitz, M.A. (1997). Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J. Cereb. Blood Flow Metab. 17, 1143-1151.
23. Anderson, G.D., Peterson, T.C., Farin, F.M., Bammler, T.K., Beyer, R.P., Kantor, E.D., and Hoane, M.R. (2013). The effect of nicotinamide on gene expression in a traumatic brain injury model. Front. Neurosci. 7, 21.
24. O'Connor, C.A., Cernak, I., and Vink, R. (2005). Both estrogen and progesterone attenuate edema formation following diffuse traumatic brain injury in rats. Brain Res. 1062, 171-174.
25. Vink, R. and Van Den Heuvel, C. (2004). Recent advances in the development of multifactorial therapies for the treatment of traumatic brain injury. Expert Opin. Investig. Drugs 13, 1263-1274.
26. Garcia-Estrada, J., Luquin, S., Fernandez, A.M., and Garcia-Segura, L.M. (1999). Dehydroepiandrosterone, pregnenolone and sex steroids down-regulate reactive astroglia in the male rat brain after a penetrating brain injury. Int. J. Dev. Neurosci. 17, 145-151.
27. Gibson, C.L., Gray, L.J., Bath, P.M., and Murphy, S.P. (2008). Progesterone for the treatment of experimental brain injury; a systematic review. Brain 131, 318-328.
28. Wright, D.W., Bauer, M.E., Hoffman, S.W., and Stein, D.G. (2001). Serum progesterone levels correlate with decreased cerebral edema after traumatic brain injury in male rats. J. Neurotrauma 18, 901-909.
29. Roof, R.L., Duvdevani, R., and Stein, D.G. (1993). Gender influences outcome of brain injury: progesterone plays a protective role. Brain Res. 607, 333-336.
30. Duvdevani, R., Roof, R.L., Fulop, Z., Hoffman, S.W., and Stein, D.G. (1995). Blood-brain barrier breakdown and edema formation following frontal cortical contusion: does hormonal status play a role? J. Neurotrauma 12, 65-75.
31. Asbury, E.T., Fritts, M.E., Horton, J.E., and Isaac, W.L. (1998). Progesterone facilitates the acquisition of avoidance learning and protects against subcortical neuronal death following prefrontal cortex ablation in the rat. Behav. Brain Res. 97, 99-106.
32. Attella, M.J., Nattinville, A., and Stein, D.G. (1987). Hormonal state affects recovery from frontal cortex lesions in adult female rats. Behav. Neural Biol. 48, 352-367.
33. Fass, B., Wrege, K., Greenough, W.T., and Stein, D.G. (1980). Behavioral symptoms following serial or simultaneous septal-forebrain lesions: similar syndromes. Physiol. Behav. 25, 683-690.
34. Stein, D.G. (2011). Is progesterone a worthy candidate as a novel therapy for traumatic brain injury? Dialogues Clin. Neurosci. 13, 352-359.
35. Feeser, V.R. and Loria, R.M. (2011). Modulation of traumatic brain injury using progesterone and the role of glial cells on its neuroprotective actions. J. Neuroimmunol. 237, 4-12.
36. Roof, R.L., Duvdevani, R., Heyburn, J.W., and Stein, D.G. (1996). Progesterone rapidly decreases brain edema: treatment delayed up to 24 hours is still effective. Exp. Neurol. 138, 246-251.
37. Guo, Q., Sayeed, I., Baronne, L.M., Hoffman, S.W., Guennoun, R., and Stein, D.G. (2006). Progesterone administration modulates AQP4 expression and edema after traumatic brain injury in male rats. Exp. Neurol. 198, 469-478.
38. Papadopoulos, M.C., and Verkman, A.S. (2007). Aquaporin-4 and brain edema. Pediatr. Nephrol. 22, 778-784.
39. Meffre, D., Delespierre, B., Gouezou, M., Leclerc, P., Vinson, G.P., Schumacher, M., Stein, D.G., and Guennoun, R. (2005). The membrane-associated progesterone-binding protein 25-Dx is expressed in brain regions involved in water homeostasis and is up-regulated after traumatic brain injury. J. Neurochem. 93, 1314-1326.
40. Ganter, S., Northoff, H., Mannel, D., and Gebicke-Harter, P.J. (1992). Growth control of cultured microglia. J. Neurosci. Res. 33, 218-230.
41. Anderson, G.D., Farin, F.M., Bammler, T.K., Beyer, R.P., Swan, A.A., Wilkerson, H.W., Kantor, E.D., and Hoane, M.R. (2011). The effect of progesterone dose on gene expression after traumatic brain injury. J. Neurotrauma 28, 1827-1843.
42. Hoane, M.R., Pierce, J.L., Holland, M.A., Birky, N.D., Dang, T., Vitek, M.P., and McKenna, S.E. (2007). The novel apolipoprotein E-based peptide COG1410 improves sensorimotor performance and reduces injury magnitude following cortical contusion injury. J. Neurotrauma 24, 1108-1118.
43. Woodlee, M.T., Asseo-Garcia, A.M., Zhao, X., Liu, S.J., Jones, T.A., and Schallert, T. (2005). Testing forelimb placing "across the midline" reveals distinct, lesion-dependent patterns of recovery in rats. Exp. Neurol. 191, 310-317.
44. Shear, D.A., Galani, R., Hoffman, S.W., and Stein, D.G. (2002). Progesterone protects against necrotic damage and behavioral abnormalities caused by traumatic brain injury. Exp. Neurol. 178, 59-67.
45. Becerra, G.D., Tatko, L.M., Pak, E.S., Murashov, A.K., and Hoane, M.R. (2007). Transplantation of GABAergic neurons but not astrocytes induces recovery of sensorimotor function in the traumatically injured brain. Behav. Brain Res. 179, 118-125.
46. Coggeshall, R.E. (1992). A consideration of neural counting methods. Trends Neurosci. 15, 9-13.
47. Hoane, M.R., Kaufman, N., Vitek, M.P., and McKenna, S.E. (2009). COG1410 improves cognitive performance and reduces cortical neuronal loss in the traumatically injured brain. J. Neurotrauma 26, 1-129.
48. Gregersen, N., Christensen, M.F., Christensen, E., and Kolvraa, S. (1986). Riboflavin responsive multiple acyl-CoA dehydrogenation deficiency. Assessment of 3 years of riboflavin treatment. Acta Paediatr. Scand. 75, 676-681.
49. Camon, E., Magrane, M., Barrell, D., Lee, V., Dimmer, E., Maslen, J., Binns, D., Harte, N., Lopez, R., and Apweiler, R. (2004). The Gene Ontology Annotation (GOA) Database: sharing knowledge in Uniprot with Gene Ontology. Nucleic Acids Res. 32, D262-D266.
50. Gentleman, R., Carey, V., Huber, W., Irizarry, R., and Dudoit, S. (2005). In: Bioinformatics and Computational Biology Solutions Using R and Bioconductor. R. Gentleman, V. Carey, W. Huber, R. Irizarry, and S. Dudoit (eds). Springer Science-Business Media, Inc: New York, pps. 397-420.
51. Wright, D.W., Ritchie, J.C., Mullins, R.E., Kellermann, A.L., and Denson, D.D. (2005). Steady-state serum concentrations of progesterone following continuous intravenous infusion in patients with acute moderate to severe traumatic brain injury. J. Clin. Pharmacol. 45, 640-648.
52. Bernier, J., Stratford, M.R., Denekamp, J., Dennis, M.F., Bieri, S., Hagen, F., Kocagoncu, O., Bolla, M., and Rojas, A. (1998). Pharmacokinetics of nicotinamide in cancer patients treated with accelerated radiotherapy: the experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer. Radiother. Oncol. 48, 123-133.
53. Horsman, M.R., Hoyer, M., Honess, D.J., Dennis, I.F., and Overgaard, J. (1993). Nicotinamide pharmacokinetics in humans and mice: a comparative assessment and the implications for radiotherapy. Radiother. Oncol. 27, 131-139.
54. Stratford, M.R., Dennis, M.F., Hoskin, P.J., Saunders, M.I., Hodgkiss, R.J., and Rojas, A. (1996). Nicotinamide pharmacokinetics in normal volunteers and patients undergoing palliative radiotherapy. Acta Oncol. 35, 213-219.
55. Hoane, M.R., Pierce, J.L., Holland, M.A., and Anderson, G.D. (2008). Nicotinamide treatment induces behavioral recovery when administered up to 4 hours following cortical contusion injury in the rat. Neuroscience 154, 861-868.
56. Cutler, S.M., Cekic, M., Miller, D.M., Wali, B., VanLandingham, J.W., and Stein, D.G. (2007). Progesterone improves acute recovery after traumatic brain injury in the aged rat. J. Neurotrauma 24, 1475-1486.
57. Wali, B., Sayeed, I., and Stein, D.G. (2011). Improved behavioral outcomes after progesterone administration in aged male rats with traumatic brain injury. Restor Neurol Neurosci 29, 61-71.
58. Cutler, S.M., Vanlandingham, J.W., and Stein, D.G. (2006). Tapered progesterone withdrawal promotes long-term recovery following brain trauma. Exp. Neurol. 200, 378-385.
59. Cutler, S.M., Pettus, E.H., Hoffman, S.W., and Stein, D.G. (2005). Tapered progesterone withdrawal enhances behavioral and molecular recovery after traumatic brain injury. Exp. Neurol. 195, 423-429.
60. Djebaili, M., Guo, Q., Pettus, E.H., Hoffman, S.W., and Stein, D.G. (2005). The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats. J. Neurotrauma 22, 106-118.
61. Jennings, J.S., Gerber, A.M., and Vallano, M.L. (2008). Pharmacological strategies for neuroprotection in traumatic brain injury. Mini Rev Med Chem 8, 689-701.
62. Baker, A.B., Gibson, W.J., Kolachalama, V.B., Golomb, M., Indolfi, L., Spruell, C., Zcharia, E., Vlodavsky, I., and Edelman, E.R. (2012). Heparanese regulates thrombosis in vascular injury and stent-induced flow disturbance. J. Am. Coll. Cardiol. 59, 1551-1560.
63. Julienne, A., Roberts, J.M., Pop, V., Murhy, P.M., Head, E., Bix, G.J., and Badaut, J. (2014). Juvenile traumatic brain injury induces long-term perivascular matrix changes alongside amyloid-beta accumulation. J. Cereb. Blood Flow Metab. 34, 1637-1645.
64. Aminmansour, B., Nikbakht, H., Ghorbani, A., Rezvani, M., Rahmani, P., Torkashvand, M., Nourian, M., and Moradi, M. (2012). Comparison of the administration of progesterone versus progesterone and vitamin D in improvement of outcomes in patients with traumatic brain injury: A randomized clinical trial with placebo group. Adv. Biomed. Res. 1, 58.
65. Atif, F., Sayeed, I., Ishrat, T., and Stein, D.G. (2009). Progesterone with vitamin D affords better neuroprotection against excitotoxicity in cultured cortical neurons than progesterone alone. Mol. Med. 15, 328-336.
66. Barbre, A.B. and Hoane, M.R. (2006). Magnesium and riboflavin combination therapy following cortical contusion injury in the rat. Brain Res. Bull. 69, 639-646.
67. Cekic, M., Cutler, S.M., VanLandingham, J.W., and Stein, D.G. (2011). Vitamin D deficiency reduces the benefits of progesterone treatment after brain injury in aged rats. Neurobiol. Aging 32, 864-874.
68. Cekic, M., Sayeed, I., and Stein, D.G. (2009). Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease. Front. Neuroendocrinol. 30, 158-172.
69. Hoane, M.R., Raad, C., and Barth, T.M. (1997). Non-competitive NMDA antagonists and anti-oxidant drugs reduce striatal atrophy and facilitate recovery of function following lesions of the rat cortex. Restor. Neurol. Neurosci. 11, 71--82.
70. Chauhan, N.B. and Gatto, R. (2010). Synergistic benefits of erythropoietin and simvastatin after traumatic brain injury. Brain Res. 1360, 177-192.